World Wires · story 22159 · unverified · 1 source(s)

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

BOSTON, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered

Open in the desk

Coverage

• Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED GlobeNewswire: public companies · tier D · clear net · 2026-10-05 20:05 UTC

What this site indexes